scispace - formally typeset
M

Marc D. Coltrera

Researcher at University of Washington

Publications -  50
Citations -  3987

Marc D. Coltrera is an academic researcher from University of Washington. The author has contributed to research in topics: Proliferating cell nuclear antigen & Cell growth. The author has an hindex of 30, co-authored 50 publications receiving 3892 citations. Previous affiliations of Marc D. Coltrera include State University of New York System & University of Washington Medical Center.

Papers
More filters
Journal Article

Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

TL;DR: Semiquantitative immunocytochemical analysis with anti-PCNA/cyclin antibodies may represent a simple, reproducible, yet powerful technique for the routine analysis of cell kinetic data in alcohol-fixed, paraffin-embedded tissue by the surgical pathologist.
Journal Article

Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.

TL;DR: This is the first demonstration of widespread p53 overexpression in alcohol-fixed, embedded tissue and confirms the major role played by p53 in human malignancies.
Journal ArticleDOI

Quality of life in patients with head and neck cancer: lessons learned from 549 prospectively evaluated patients.

TL;DR: Quality-of-life research findings for patients with head and neck cancer are summarized, areas for future productive QOL research are suggested, and how to undertake QOL studies in a cost-effective manner is discussed.
Journal ArticleDOI

FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.

TL;DR: This pilot study prospectively examined the use of registered 18-F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT for preradiotherapy staging of the neck and suggested that FDG-PET/CT is superior to CT alone for geographic localization of diseased neck node levels.
Journal ArticleDOI

Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R).

TL;DR: The UW-QOL can be effectively and accurately used to compare treatment effects in the management of head and neck cancer and this revised instrument appears to measure the domains of overall QOL in a highly consistent and reliable fashion over time.